Atika Capital Management LLC Esperion Therapeutics, Inc. Transaction History

Atika Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$36.2 - $76.4 $1.45 Million - $3.06 Million	-40,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$65.94 - $80.76 $1.06 Million - $1.29 Million	-16,000 Reduced 28.57%	40,000 $2.89 Million
Q4 2017 Feb 14, 2018	BUY	$43.47 - $67.43 $1.84 Million - $2.85 Million	42,300 Added 308.76%	56,000 $3.69 Million
Q3 2017 Nov 14, 2017	BUY	$43.8 - $52.77 $600,060 - $722,949	13,700	13,700 $686,000

206

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $153M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.